This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Questions about our CME?
Questions about our CME?
Opportunities to Individualize Treatment and Alter the Course of Interstitial Lung Disease—Webcast

Opportunities to Individualize Treatment and Alter the Course of Interstitial Lung Disease—Webcast

Format

Webcast

Time to Complete

1 hour

Released

August 31, 2017

Expires

August 31, 2018
Add to Queue


Maximum Credits

1.00 / AMA PRA Category 1 CreditTM
1.00 / CE for Nurses (0.50 pharmacology credits)
1.00 / CE for Pharmacists (0.10 CEUs)

Accredited Provider

Jointly provided by Global Education Group and Integrity Continuing Education

Commercial Supporter

Supported by an educational grant from Boehringer Ingelheim

Program Description

Although once considered rare, epidemiologic investigations have revealed interstitial lung disease (ILD) to be significantly more common than previously recognized. Previously, it has been reported that 80.9 per 100,000 men and 67.2 per 100,000 women suffer from ILD in the US, with 31.5 new cases diagnosed per 100,000 men per year and 26.1 new cases diagnosed per 100,000 women per year. Certain ILDs (eg, sarcoidosis, pulmonary Langerhans cell histiocytosis, and autoimmune-associated lung diseases) appear to develop more frequently during young adulthood, whereas idiopathic pulmonary fibrosis (IPF) occurs most often between the ages of 40 and 70. Both the incidence and associated mortality of ILD increases with age, and consistent with the expansion of elderly populations, recent evidence indicates that the number of new cases diagnosed per year and the mortality rates continue to rise.

Hospital Medicine Summit (HMS) is an innovative, multi-topic educational initiative designed specifically for hospital-based healthcare providers (hospitalists, internal medicine physicians, physician assistants, nurse practitioners, pharmacists, and nurses). With significant changes occurring in the healthcare system, there is an increased demand on hospital-based healthcare providers to provide care that impacts patients not only in the acute setting, but as they transition back into the community and are managed in the chronic-care healthcare system.

Intended Audience

This educational initiative has been designed for hospital-based healthcare providers, including physicians, physician assistants, nurse practitioners, registered nurses, and pharmacists.

Educational Objectives

Upon completion of this educational activity, participants should be able to:

  • Outline a multidisciplinary approach for the differential diagnosis of interstitial lung disease (ILD)
  • Discuss the latest evidence-based guidelines for idiopathic pulmonary fibrosis (IPF) and review strategies for individualized ILD management
  • Describe strategies for ensuring adequate clinician-patient communication over the course of ILD management

Conflict Of Interest Disclosure Policy

Integrity Continuing Education, Inc. and Global Education Group require instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Integrity Continuing Education and Global Education Group for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Integrity Continuing Education and Global Education Group are committed to providing learners with high-quality CME/CE activities and related materials that promote improvement or quality in healthcare and not a specific proprietary business interest or a commercial interest.

The following faculty/planners reported their financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Faculty

Paul W. Noble, MD
Chair, Department of Medicine
Vera and Paul Guerin Family Distinguished Chair in Pulmonary Medicine
Director, Women’s Guild Lung Institute
Cedars-Sinai Medical Center
Los Angeles, CA

Dr. Noble discloses the following:
Consultant: Boehringer Ingelheim, Genentech, Roche

Planners and Managers Disclosures

The following planners and managers, Andrea Funk, Liddy Knight, Lindsay Borvansky, Ashley Marostica, RN, MSN, and Patima Tanapat, PhD, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Credit

1.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

Integrity Continuing Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education (CME) for physicians.

Designation Statement

Integrity Continuing Education designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM  . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit

1.00

Type

CE for Nurses

Accreditation Statement

Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Designation Statement

This educational activity for 1.00 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Designated for 0.50 contact hours of pharmacotherapy credit for Advance Practice Registered Nurses.

Credit

1.00

Type

CE for Pharmacists

Accreditation Statement

Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Designation Statement

Global Education Group designates this continuing education activity for 1.00 contact hour(s) (0.10 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number: 0530-9999-17-168-H01-P)

Activity Type: Knowledge

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Integrity Continuing Education, Global Education Group, and Boehringer Ingelheim, do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Integrity Continuing Education, Global Education Group, and Boehringer Ingelheim. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition.

Instructions

There are no fees for participating and receiving CME credit for this activity. During the period of August 31, 2017 through August 31, 2018, participants must:

  • Read the learning objectives and faculty disclosures
  • Complete the pre-test
  • Study the educational activity
  • Complete the post-test and the evaluation form
A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed post-test with a score of 70%.

For information about ACCME accreditation of this activity, please contact Integrity Continuing Education at (855) 835-4004 or hms@integrityce.com.

For information about ACPE or ANCC accreditation of this activity, please contact Global at (303) 395-1782 or cme@globaleducationgroup.com.

If you have any questions relating to your certificate or other issues with this activity, please contact myCME.Support@haymarketmedical.com.

Privacy Policy

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue